XML 38 R22.htm IDEA: XBRL DOCUMENT v3.22.0.1
Supplemental Financial Information
 12 Months Ended
Dec. 25, 2021
Supplemental Financial Information [Abstract]  
Additional Financial Information Disclosure [Text Block] Supplemental Financial Information
Balance Sheet
202120202019
Accounts and notes receivable
Trade receivables$7,172 $6,892 
Other receivables1,655 1,713 
Total8,827 8,605 
Allowance, beginning of year201 105 $101 
Cumulative effect of accounting change— 44 — 
Net amounts charged to expense (a)
(19)79 22 
Deductions (b)
(25)(32)(30)
Other (c)
(10)5 12 
Allowance, end of year147 201 $105 
Net receivables$8,680 $8,404 
Inventories (d)
Raw materials and packaging $1,898 $1,720 
Work-in-process151 205 
Finished goods2,298 2,247 
Total$4,347 $4,172 
Property, plant and equipment, net (e)
Average
Useful Life (Years)
Land $1,123 $1,171 
Buildings and improvements
15 - 44
10,279 10,214 
Machinery and equipment, including fleet and software
5 - 15
31,486 31,276 
Construction in progress3,940 3,679 
46,828 46,340 
Accumulated depreciation(24,421)(24,971)
Total$22,407 $21,369 
Depreciation expense$2,484 $2,335 $2,257 
Other assets
Noncurrent notes and accounts receivable$111 $109 
Deferred marketplace spending119 130 
Pension plans (f)
1,260 910 
Right-of-use assets (g)
2,020 1,670 
Other694 493 
Total$4,204 $3,312 
Accounts payable and other current liabilities
Accounts payable (h)
$9,834 $8,853 
Accrued marketplace spending3,087 2,935 
Accrued compensation and benefits2,324 2,059 
Dividends payable1,508 1,430 
Current lease liabilities (g)
446 460 
Other current liabilities 3,960 3,855 
Total$21,159 $19,592 
(a)2021 includes reductions in the previously recorded reserves of $32 million, while 2020 includes an allowance for expected credit losses of $56 million, related to the COVID-19 pandemic. See Note 1 for further information.
(b)Includes accounts written off.
(c)Includes adjustments related primarily to currency translation and other adjustments.
(d)Approximately 7% and 6% of the inventory cost in 2021 and 2020, respectively, were computed using the LIFO method. The differences between LIFO and FIFO methods of valuing these inventories were not material. See Note 2 for further information.
(e)See Note 2 for further information.
(f)See Note 7 for further information.
(g)See Note 12 for further information.
(h)Increase reflects higher production payables due to strong business performance across a number of our divisions as well as higher commodity prices, partially offset by liabilities reclassified as held for sale in connection with our Juice Transaction.
Statement of Cash Flows
202120202019
Interest paid (a)
$1,184 $1,156 $1,076 
Income taxes paid, net of refunds (b)
$1,933 $1,770 $2,226 
(a)In 2021, excludes the charge related to cash tender offers. See Note 8 for further information.
(b)In 2021, 2020 and 2019, includes tax payments of $309 million, $78 million and $423 million, respectively, related to the TCJ Act.
The following table provides a reconciliation of cash and cash equivalents and restricted cash as reported within the balance sheet to the same items as reported in the cash flow statement.
20212020
Cash and cash equivalents$5,596 $8,185 
Restricted cash included in other assets (a)
111 69 
Total cash and cash equivalents and restricted cash$5,707 $8,254 
    
(a)Primarily relates to collateral posted against certain of our derivative positions.